Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Alzheimer Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00097916
What this trial is testing

An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Forest Laboratories 34
Testing effectiveness (Phase 2)Study completedNCT01527916
What this trial is testing

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AbbVie (prior sponsor, Abbott) 438
Testing effectiveness (Phase 2)UnknownNCT02833792
What this trial is testing

Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease

Who this might be right for
Alzheimer Dementia
Stemedica Cell Technologies, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT04070378
What this trial is testing

Study of Daratumumab in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Marc L Gordon, MD 16
Not applicableStudy completedNCT01081743
What this trial is testing

Effectiveness of Care Management in Alzheimer Patients

Who this might be right for
Alzheimer Disease or Associated DisorderMild to Moderately Severe Dementia
Institut de Sante Publique, d'Epidemiologie et de Developpement 270
Large-scale testing (Phase 3)Study completedNCT04669028
What this trial is testing

NE3107 in Probable Alzheimer's Disease

Who this might be right for
Alzheimer Disease
BioVie Inc. 439
Testing effectiveness (Phase 2)Study completedNCT00812565
What this trial is testing

Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Octapharma 58
Testing effectiveness (Phase 2)Study completedNCT00568776
What this trial is testing

ELND005 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
OPKO Health, Inc. 353
Large-scale testing (Phase 3)Looking for participantsNCT06976203
What this trial is testing

Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

Who this might be right for
Alzheimer's Disease
Bristol-Myers Squibb 586
Large-scale testing (Phase 3)Study completedNCT00818662
What this trial is testing

Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease

Who this might be right for
Alzheimer´s Disease
Baxalta now part of Shire 390
Large-scale testing (Phase 3)Ended earlyNCT01739348
What this trial is testing

An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 2,211
Testing effectiveness (Phase 2)UnknownNCT01255046
What this trial is testing

Study of STA-1 as an Add-on Treatment to Donepezil

Who this might be right for
Alzheimer Disease
Sinphar Pharmaceutical Co., Ltd 136
Large-scale testing (Phase 3)Ended earlyNCT00937352
What this trial is testing

A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 896
Large-scale testing (Phase 3)Not Yet RecruitingNCT06964230
What this trial is testing

A Phase 2b/3 Clinical Study Evaluating T3D-959 in Mild-to-Moderate Alzheimer's Disease Subjects

Who this might be right for
Alzheimer's Disease
T3D Therapeutics, Inc. 376
Testing effectiveness (Phase 2)Study completedNCT00663936
What this trial is testing

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
FUJIFILM Toyama Chemical Co., Ltd. 373
Not applicableStudy completedNCT02973971
What this trial is testing

ADDIA Chronobiological Study

Who this might be right for
Alzheimer Disease
Amoneta Diagnostics SAS 24
Testing effectiveness (Phase 2)Looking for participantsNCT06597942
What this trial is testing

Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD)

Who this might be right for
Alzheimer&Amp;Amp;#39;s DiseaseAlzheimer DiseaseDementia Alzheimer Type+4 more
University of California, Los Angeles 54
Early research (Phase 1)Study completedNCT01193608
What this trial is testing

Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 88
Testing effectiveness (Phase 2)Study completedNCT00099710
What this trial is testing

Curcumin in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
John Douglas French Foundation 33
Large-scale testing (Phase 3)Study completedNCT00104013
What this trial is testing

Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Disease
Sanofi 1,455
Next Page